Arrowhead Pharmaceuticals Inc. trailing returns
Arrowhead Pharmaceuticals Inc.'s 10-year return is +25.3% a year (CAGR) (+853.2% cumulative). How Arrowhead Pharmaceuticals Inc. (ARWR) has performed over the last day, week, month and year, over 5, 10, 20 and 30 years, and since inception, through November 17, 2026 — price return and dividends side by side, with the worst drop inside each window.
Trailing returns by period#
Data provided bySource: Twelve DataTo 2026-11-17. Price return + dividends = total return. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.
| Period | Price | DivsDividends | Total | Worst drop |
|---|---|---|---|---|
| Cumulative · the change over the window | ||||
| 1 day | -2.8% | +0.0% | -2.8% | — |
| 5 days | -12.3% | +0.0% | -12.3% | -12.9%Nov 17 |
| 1 month | -23.1% | +0.0% | -23.1% | -30.3%Nov 17 |
| YTD | -35.2% | +0.0% | -35.2% | -52.0%Nov 17 |
| Per year (CAGR) · the cumulative total return beneath | ||||
| 1 year | +7.1% | +0.0% | +7.1% CAGR | -52.0%Nov 2026 |
| 5 years | -7.6% | +0.0% | -7.6% CAGR-32.6% total | -86.5%Apr 2025 |
| 10 years | +25.3% | +0.0% | +25.3% CAGR+853.2% total | -89.0%Apr 2025 |
| 20 years | -0.5% | +0.0% | -0.5% CAGR-9.7% total | -98.4%Dec 2016 |
| 30 years | -5.0% | +0.0% | -5.0% CAGR-78.9% total | -99.4%Dec 2016 |
| Since 1993Since inception (1993) | -12.0% | +0.0% | -12.0% CAGR-98.5% total | -100.0%Dec 2016 |
Growth of ARWR#
Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.
- 5 years-7.6%/year · -32.6%
- 10 years+25.3%/year · +853.2%
- 20 years-0.5%/year · -9.7%
- 30 years-5.0%/year · -78.9%
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-11-17). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in ARWR's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Arrowhead Pharmaceuticals Inc.'s 10-year return?
- Over the last 10 years, Arrowhead Pharmaceuticals Inc. (ARWR) returned about +25.3% a year annualized (+853.2% cumulative total return).
- What is Arrowhead Pharmaceuticals Inc.'s 20-year annualized return?
- Over the last 20 years, Arrowhead Pharmaceuticals Inc. (ARWR) compounded at about -0.5% a year (-9.7% cumulative).
- What is Arrowhead Pharmaceuticals Inc.'s 30-year annualized return?
- Over the last 30 years, Arrowhead Pharmaceuticals Inc. (ARWR) compounded at about -5.0% a year (-78.9% cumulative).
- What is Arrowhead Pharmaceuticals Inc.'s return since inception?
- Since 1993, Arrowhead Pharmaceuticals Inc. (ARWR) has compounded at about -12.0% a year — -98.5% in total.
